DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Dimopoulos MA, Trotman J, Tedeschi A, Matous JV, Macdonald D, Tam C. et al.
iNNOVATE Study Group and the European Consortium for Waldenström's Macroglobulinemia. Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): An open-label substudy of an international, multicentre, phase 3 trial.
Lancet Oncol 2017;
18: 241-50
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.